Rakovina Therapeutics Inc.

C$0.20As of Sun 8 Nov 2026, 12:00 UTC
TSXV:RKVHealthcare
Country Canada
PE (Fwd) •••
TSR 6Y CAGR (34.08%)
Div yield —
ROE (1352.29%)
Biotechnology
Beta (5Y) (0.27)
PE TTM —
TSR TTM 5.26%
Mkt cap C$8.918M
ROIC (111.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.204
2.15%
(77.81%)
Hold 7|9|4|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
17.23%
5.41%
7.11%
8.38%
Revenue$M
0.445
0.461
0.482
0.482
2.08%
7.28%
15.45%
12.67%
Peers (US$6.312M)
Cap (US$)
PE
6.316M
—
Capital
TTM
5Y
10Y
Leveragex
0.955
(0.155)
(0.145)
EBIT/Intx
2.604
0.095
0.095
Own earn%
(12.75)
(6.78)
(10.89)
Sh yield%
7.75
21.43
24.58
Owners
Insiders/Inst%
2.89
37.69
Short interest%
3.10
SBC / revenue%
3.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
3–9
$1 testx
0.0
Incr. ROIC%
6